These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8829704)

  • 1. Cardiovascular disease in women: implications of hormone replacement therapy.
    Sarrel PM
    Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
    Chew S; Ng SC
    Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestins and androgens.
    Whitehead M
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):161S-167S. PubMed ID: 7958012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
    Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
    J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
    Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
    Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications].
    Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
    Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J
    Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of estrogens and progestogens and cardiovascular risk].
    Boissel JP; Cornu C
    Therapie; 1999; 54(3):387-92. PubMed ID: 10500456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic and cardiovascular consequences of HRT.
    Stevenson JC
    Br J Clin Pract; 1995; 49(2):87-90. PubMed ID: 7779651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of estrogen replacement and exercise protects against HDL oxidation in post-menopausal women.
    Lawler JM; Hu Z; Green JS; Crouse SF; Grandjean PW; Bounds RG
    Int J Sports Med; 2002 Oct; 23(7):477-83. PubMed ID: 12402178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
    Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
    Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens, progestins, selective estrogen receptor modulators, and the arterial tree.
    Wild RA; Reis SE
    Am J Obstet Gynecol; 2001 Apr; 184(5):1031-9. PubMed ID: 11303216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis and estrogen replacement therapy.
    Sullivan JM
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():28-35. PubMed ID: 8199638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.